# Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients

> **NCT01385696** · PHASE3 · COMPLETED · sponsor: **Almirall, S.A.** · enrollment: 130 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DEVICE:** Genuair® (Almirall S.A.)
- **DEVICE:** HandiHaler® (Boehringer Ingelheim's)

## Key facts

- **NCT ID:** NCT01385696
- **Lead sponsor:** Almirall, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2015-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01385696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01385696, "Study Evaluating Preference, Satisfaction and Ease of Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD) Diagnosed Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01385696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
